삼성서울병원

Ko En

유방외과분과 채병주 교수

진료분야
유방암수술, 유방악성질환, 유방암
진료일정 04 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
오전
오후
진료일정 05 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
오전
오후

학력

학력
2010.02 가톨릭대학교 의학대학원 의학 박사 졸업
2004.02 가톨릭대학교 의학대학원 의학 석사 졸업
2000.02 가톨릭대학교 의과대학 졸업

경력

경력
2023.04 ~현재 삼성서울병원 외과 의국장
2022.03 ~현재 성균관대학교 의과대학 외과학교실 교수
2021.12 ~현재 삼성서울병원 외래부차장
2019.03 ~ 2022.02 삼성서울병원 전임대우 부교수
2019.02 ~ 2019.02 삼성서울병원 진료 부교수
2017.09 ~ 2019.01 가톨릭대학교 서울성모병원 홍보부실장
2017.03 ~ 2019.01 가톨릭대학교 서울성모병원 부교수
2013.03 ~ 2017.02 가톨릭대학교 서울성모병원 조교수
2014.03 ~ 2015.02 MD Anderson Cancer Center Visiting Assistant Professor
2011.03 ~ 2013.02 서울성모병원 임상조교수
2008.05 ~ 2011.02 서울성모병원 임상강사
2010.04 ~ 2010.04 European Institute of Oncology, Milan, Italia--Visiting doctor
2005.04 ~ 2008.04 태안군보건의료원 공중보건의
2001.03 ~ 2004.02 가톨릭 중앙의료원 전공의

학회활동

학회활동
2024.04 ~ 현재 대한의학회 건강정보심의위원회 위원
2023.05 ~ 현재 Global Breast Cancer Conference 조직위원회 사무총장
2023.05 ~ 현재 한국유방암학회 총무이사
2016.10 ~ 현재 FACS. Fellow of American College of Surgeon
2008.09 ~ 현재 대한외과종양학회 정회원
2021.05 ~ 2023.04 한국유방암학회 기획이사
2020.10 ~ 2022.09 대한암학회 홍보 부위원장
2019.05 ~ 2021.04 Global Breast Cancer Conference 조직위원회 사무총장
2019.05 ~ 2021.04 한국유방암학회 총무이사
2015.05 ~ 2021.04 한국유방암학회 임상시험위원회 위원
2015.05 ~ 2021.04 한국유방암학회 임상시험위원회 위원
2017.05 ~ 2019.04 Global Breast Cancer Conference 사무차장
2017.05 ~ 2019.04 한국유방암학회 간사
2017.05 ~ 2019.04 한국유방암학회 교육위원회 간사
2015.05 ~ 2019.04 한국유방암학회 교과서편찬위원회 간사
2015.05 ~ 2019.04 한국유방암학회 학술위원회 간사
2015.11 ~ 2017.10 대한외과학회 학술위원회 위원
2015.05 ~ 2017.04 Global Breast Cancer Conference 사무차장보
2015.05 ~ 2017.04 한국유방암학회 교육위원회 위원
2015.05 ~ 2017.04 한국유방암학회 진료권고안위원회 위원

수상이력

수상이력
2010.04 2010 춘계유방암학회 학술상
2009.06 서울성모병원 친절교원상
2008.07 4th Inter-American Breast Cancer Conference Best poster Award 수상
  • BREAST CANCER-TOKYO 2024 10.1007/s12282-024-01547-9 Outcomes of whole breast radiation therapy in Asian breast cancer patients with prior cosmetic implants Kim, N; Cho, WK; Park, W; Lee, JE; Nam, SJ; Kim, SW; Yu, JH; Chae, BJ; Lee, SK; Ryu, JM; Ko, ES; Kim, H
    View PubMed
  • BREAST 2023 10.1016/j.breast.2023.103594 Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/ pertuzumab for HER2-positive breast cancer Kim, N; Kim, JY; Park, W; Cho, WK; Kim, TG; Im, YH; Ahn, JS; Lee, JE; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Lee, SK; Ryu, JM; Park, YH; Kim, H
    View PubMed
  • CANCERS 2023 10.3390/cancers15225473 The Role of Post-Mastectomy Radiotherapy in T1-2N1 Breast Cancer Patients: Propensity Score Matched Analysis Kim, K; Park, W; Kim, H; Cho, WK; Kim, N; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Chae, BJ; Lee, SK; Ryu, JM
    View PubMed
  • CANCERS 2023 10.3390/cancers15225361 The Impact of HER2-Low Expression on Oncologic Outcomes in Hormone Receptor-Positive Breast Cancer Park, WK; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Ryu, JM; Chae, BJ
    View PubMed
  • FRONT ONCOL 2023 10.3389/fonc.2023.1230310 Risk factors of breast cancer recurrence in pathologic complete response achieved by patients following neoadjuvant chemotherapy: a single-center retrospective study Choi, JY; Woen, D; Jang, SY; Lee, H; Shin, DS; Kwak, Y; Lee, H; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
    View PubMed
  • WORLD J CLIN CASES 2023 10.12998/wjcc.v11.i27.6398 Oncologic efficacy of gonadotropin-releasing hormone agonist in hormone receptor-positive very young breast cancer patients treated with neoadjuvant chemotherapy Choi, HJ; Lee, JH; Jung, CS; Ryu, JM; Chae, BJ; Lee, SK; Yu, JH; Kim, SW; Nam, SJ; Lee, JE; Jung, YJ; Kim, HY
    View PubMed
  • JMIR PUBLIC HLTH SUR 2023 10.2196/45212 Prediction Model for Postoperative Quality of Life Among Breast Cancer Survivors Along the Survivorship Trajectory From Pretreatment to 5 Years: Machine Learning-Based Analysis Kang, D; Kim, H; Cho, J; Kim, Z; Chung, M; Lee, JE; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Ryu, JM; Lee, SK
    View PubMed
  • CANCERS 2023 10.3390/cancers15133435 Progesterone Receptor Expression Level Predicts Prognosis of Estrogen Receptor-Positive/HER2-Negative Young Breast Cancer: A Single-Center Prospective Cohort Study Kwak, Y; Jang, SY; Choi, JY; Lee, H; Shin, DS; Park, YH; Kim, JY; Ahn, JS; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
    View PubMed
  • EXP MOL MED 2023 10.1038/s12276-023-01030-z Genomic characteristics of triple negative apocrine carcinoma: a comparison to triple negative breast cancer Kim, JY; Park, S; Cho, EY; Lee, JE; Jung, HH; Chae, BJ; Kim, SW; Nam, SJ; Cho, SY; Park, YH; Ahn, JS; Lee, S; Im, YH
    View PubMed
  • ANN SURG TREAT RES 2023 10.4174/astr.2023.105.1.10 Trends of axillary surgery in breast cancer patients with axillary lymph node metastasis: a comprehensive single-center retrospective study Kim, YJ; Kim, HJ; Chung, SY; Lee, SK; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
    View PubMed
  • J BREAST CANCER 2023 10.4048/jbc.2023.26.e11 Impact of Adjuvant Hormone Therapy on Sleep, Physical Activity, and Quality of Life in Premenopausal Breast Cancer: 12-Month Observational Study Yeo, SM; Lim, JY; Kim, SW; Chae, BJ; Yu, JH; Ryu, JM; Hwang, JH
    View PubMed
  • CANCERS 2023 10.3390/cancers15051556 Clinical Characteristics and Prognosis of Metaplastic Breast Cancer Compared with Invasive Ductal Carcinoma: A Propensity-Matched Analysis Lee, JH; Ryu, JM; Lee, SK; Chae, BJ; Lee, JE; Kim, SW; Nam, SJ; Yu, J
    View PubMed
  • FRONT ONCOL 2023 10.3389/fonc.2023.1039670 The efficacy and safety of an indocyanine green-hyaluronic acid mixture (LuminoMark (TM)) for localization in patients with non-palpable breast lesions: A multicenter, randomized, open-label, parallel phase 3 clinical trial Bang, YJ; Choi, HJ; Kim, I; Lee, MH; Lee, SY; Shin, HJ; Nam, SJ; Lee, JE; Chae, BJ; Lee, SK; Ryu, JM; Kim, SW
    View PubMed
  • HEALTH INFORM J 2023 10.1177/14604582231156476 Feasibility and usability of a personalized mHealth app for self-management in the first year following breast cancer surgery Lim, JY; Kim, Y; Yeo, SM; Chae, BJ; Yu, JH; Hwang, JH
    View PubMed
  • BREAST 2022 10.1016/j.breast.2022.09.004 Suggestion for the omission of post-mastectomy chest wall radiation therapy in patients who underwent skin-sparing/ nipple-sparing mastectomy Kim, N; Park, W; Cho, WK; Kim, HY; Choi, DH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Chae, BJ; Lee, SK; Ryu, JM; Mun, GH; Pyon, JK; Jeon, BJ
    View PubMed
  • J BREAST CANCER 2022 10.4048/jbc.2022.25.e49 Predicting the Response of Neoadjuvant Chemotherapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer With Axillary Lymph Node Metastasis by Multigene Assay Lee, JH; Ryu, JM; Ahn, JH; Cho, SY; Lee, SK; Yu, J; Chae, BJ; Nam, SJ; Han, J; Lee, JE; Kim, SW
    View PubMed
  • J CLIN MED 2022 10.3390/jcm11216564 Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy? Choi, HJ; Ryu, JM; Lee, JH; Bang, Y; Oh, J; Chae, BJ; Nam, SJ; Kim, SW; Lee, JE; Lee, SK; Yu, J
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2021.901 Real World Evidence of Neoadjuvant Docetaxel/Carboplatin/Trastuzumab/ Pertuzumab (TCHP) in Patients with HER2-Positive Early or Locally Advanced Breast Cancer: A Single-Institutional Clinical Experience Kim, JY; Nam, SJ; Lee, JE; Yu, J; Chae, BJ; Lee, SK; Ryu, JM; Ahn, JS; Im, YH; Kim, SW; Park, YH
    View PubMed
  • CANCERS 2022 10.3390/cancers14194839 Long-Term Breast Cancer Outcomes of Pregnancy-Associated Breast Cancer (PABC) in a Prospective Cohort Jo, H; Park, S; Kim, HR; Kim, H; Hong, J; Lee, JE; Yu, J; Chae, BJ; Lee, SK; Ryu, JM; Oh, SY; Choi, SJ; Kim, JY; Ahn, JS; Im, YH; Nam, EM; Nam, SJ; Park, YH
    View PubMed
  • J BREAST CANCER 2022 10.4048/jbc.2022.25.e33 Multicentric Breast Cancer of the Axillary and Pectoral Breasts: A Case Report and Literature Review Kim, H; Ko, EY; Han, BK; Kim, JY; Chae, BJ; Lee, H
    View PubMed
  • J BREAST CANCER 2022 10.4048/jbc.2022.25.e36 Comparison of Recurrence Rate Between Re-Excision With Radiotherapy and Radiotherapy-Only Groups in Surgical Margin Involvement of In Situ Carcinoma Lee, JH; Lee, H; Bang, YJ; Ryu, JM; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Chae, BJ
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2021.784 Validation of Korean Version of the COmprehensive Score for Financial Toxicity (COST) among Breast Cancer Survivors Shim, S; Kang, D; Kim, N; Han, G; Lim, J; Kim, H; Park, J; Lee, M; Lee, JE; Kim, SW; Yu, J; Chae, BJ; Ryu, JM; Nam, SJ; Lee, SK; Cho, J
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2021.791 Clinicopathological Characterization of Double Heterozygosity for BRCA1 and BRCA2 Variants in Korean Breast Cancer Patients Bang, YJ; Kwon, WK; Nam, SJ; Kim, SW; Chae, BJ; Lee, SK; Ryu, JM; Kim, JW; Yu, J; Lee, JE
    View PubMed
  • BREAST CANCER RES TR 2022 10.1007/s10549-021-06500-4 Surgical margin status and survival outcomes of breast cancer patients treated with breast-conserving surgery and whole-breast irradiation after neoadjuvant chemotherapy Cheun, JH; Lee, YJ; Lee, JH; Shin, Y; Chun, JW; Baek, SY; Kim, HK; Lee, HB; Yu, J; Chae, BJ; Han, W; Lee, JE
    View PubMed
  • CURR ONCOL 2022 10.3390/curroncol29050267 Primary Angiosarcoma of the Breast: A Single-Center Retrospective Study in Korea Kim, YJ; Ryu, JM; Lee, SK; Chae, BJ; Kim, SW; Nam, SJ; Yu, JH; Lee, JE
    View PubMed
  • BREAST CANCER RES TR 2022 10.1007/s10549-021-06437-8 A triple-negative breast cancer surrogate subtype classification that correlates with gene expression subtypes Yoo, TK; Kang, J; Lee, A; Chae, BJ
    View PubMed
  • J BREAST CANCER 2021 10.4048/jbc.2021.24.e51 A Randomized Controlled Trial for Doing vs. Omitting Intraoperative Frozen Section Biopsy for Resection Margin Status in Selected Patients Undergoing Breast-Conserving Surgery (OFF-MAP Trial) Yoo, TK; Kang, YJ; Jeong, J; Song, JY; Kang, SH; Lee, HY; Kim, ET; Yi, O; Lee, HB; Choi, S; Park, HS; Gwak, G; Kim, JI; Kim, MK; Lee, J; Kang, HJ; Chae, BJ
    View PubMed
  • J CLIN MED 2021 10.3390/jcm10204754 Is Sentinel Lymph Node Biopsy for Breast Cancer with Cytology-Proven Axillary Metastasis Safe? A Prospective Single-Arm Study Choi, HJ; Ryu, JM; Chae, BJ; Nam, SJ; Yu, J; Lee, SK; Lee, JE; Kim, SW
    View PubMed
  • J BREAST CANCER 2021 10.4048/jbc.2021.24.e30 Effect of Poloxamer-Based Thermo- Sensitive Sol-Gel Agent on Upper Limb Dysfunction after Axillary Lymph Node Dissection: A Double-Blind Randomized Clinical Trial Choi, HJ; Ryu, JM; Chae, BJ; Kim, EK; Min, JW; Shin, HJ; Nam, SJ; Yu, J; Lee, JE; Lee, SK; Kim, SW
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-94195-4 Preoperative diagnosis of BRCA1/2 mutation impacts decision-making for risk-reducing mastectomy in breast cancer patients Woo, J; Gwak, G; Park, I; Bae, BN; Lee, SK; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
    View PubMed
  • BMC CANCER 2021 10.1186/s12885-021-08494-0 Cardiovascular events and mortality in a population-based cohort initially diagnosed with ductal carcinoma in situ Yoo1, TK; Park, SH; Han, KD; Chae, BJ
    View PubMed
  • FRONT ONCOL 2021 10.3389/fonc.2021.691277 Validation of the Clinical Treatment Score Post-Five Years in Breast Cancer Patients for Predicting Late Distant Recurrence: A Single-Center Investigation in Korea Lee1, JH; Lee, SK; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
    View PubMed
  • BMC CANCER 2021 10.1186/s12885-021-08355-w Response to neoadjuvant chemotherapy based on pathologic complete response in very young patients with ER-positive breast cancer: a large, multicenter, observational study Woo1, J; Oh, SJ; Song, JY; Chae, BJ; Choi, JE; Lee, J; Park, HK; Lim, W
    View PubMed
  • CANCERS 2021 10.3390/cancers13051177 Changes in Metabolic Syndrome Status and Breast Cancer Risk: A Nationwide Cohort Study Choi1, IY; Chun, S; Shin, DW; Han, K; Jeon, KH; Yu, J; Chae, BJ; Suh, M; Park, YM
    View PubMed
  • J BREAST CANC 2021 10.4048/jbc.2021.24.e4 Relation Between Tumor Size and Lymph Node Metastasis According to Subtypes of Breast Cancer Min1, SK; Lee, SK; Woo, J; Jung, SM; Ryu, JM; Yu, J; Lee, JE; Kim, SW; Chae, BJ; Nam, SJ
    View PubMed
  • EJSO-EUR J SURG ONC 2021 10.1016/j.ejso.2020.08.023 Breast radiologic complete response is associated with favorable survival outcomes after neoadjuvant chemotherapy in breast cancer Woo1, J; Ryu, JM; Jung, SM; Choi, HJ; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Chae, BJ
    View PubMed
  • BMC CANCER 2021 10.1186/s12885-020-07729-w Does chemotherapy or radiotherapy affect the postoperative complication in breast cancer patients who underwent immediate breast reconstruction with tissue expander? Jung1, SM; Jeon, BJ; Woo, J; Ryu, JM; Lee, SK; Chae, BJ; Yu, J; Kim, SW; Nam, SJ; Pyon, JK; Mun, GH; Bang, SI; Lee, JE
    View PubMed
  • ANN SURG TREAT RES 2020 10.4174/astr.2020.99.5.251 Is the intraoperative frozen section analysis of sentinel lymph nodes necessary in clinically negative node breast cancer? Jung1, SM; Woo, J; Ryu, JM; Lee, SK; Chae, BJ; Yu, J; Kim, SW; Nam, SJ; Kim, EJ; Lee, JE
    View PubMed
  • CANCER EPIDEM BIOMAR 2020 10.1158/1055-9965.EPI-20-0038 Hormone Replacement Therapy, Breast Cancer Risk Factors, and Breast Cancer Risk A Nationwide Population-Based Cohort Yoo1, TK; Han, KD; Kim, D; Ahn, J; Park, WC; Chae, BJ
    View PubMed
  • BREAST CANCER RES TR 2020 10.1007/s10549-020-05636-z Axillary lymph node dissection is not obligatory in breast cancer patients with biopsy-proven axillary lymph node metastasis Yoo1, TK; Kang, BJ; Kim, SH; Song, BJ; Ahn, J; Park, WC; Chae, BJ
    View PubMed
  • CLIN BREAST CANCER 2020 10.1016/j.clbc.2019.11.011 A N0 Predicting Model for Sentinel Lymph Node Biopsy Omission in Early Breast Cancer Upstaged From Ductal Carcinoma in Situ Yoo1, TK; Kim, SJ; Lee, J; Lee, SB; Lee, SJ; Park, HY; Park, HK; Chae, BJ; Eom, YH; Kim, HS; Song, BJ
    View PubMed
  • J CLIN MED 2020 10.3390/jcm9041192 Aberrant Lymphatic Drainage in the Contralateral Axilla in Patients with Isolated Ipsilateral Breast Tumor Recurrence Ryu1, JM; Chae, BJ; Lee, JE; Yu, J; Nam, SJ; Kim, SW; Lee, SK
    View PubMed
  • BREAST CANCER RES TR 2020 10.1007/s10549-020-05550-4 The prognostic value of HER2 status and efficacy of anti-HER2 therapy in patients with HR-positive mucinous breast cancer: a nationwide study from the Korean Breast Cancer Society Kim1, HS; Yoo, TK; Park, WC; Chae, BJ
    View PubMed
  • JPN J CLIN ONCOL 2020 10.1093/jjco/hyz147 Prognosis of BRCA1/2-negative breast cancer patients with HBOC risk factors compared with sporadic breast cancer patients without HBOC risk factors Ryu1, JM; Nam, SJ; Kim, SW; Lee, JE; Chae, BJ; Lee, SK; Yu, J
    View PubMed
  • J BREAST CANC 2019 10.4048/jbc.2019.22.e48 Oncologic Outcomes of Nipple-Sparing Mastectomy with Immediate Breast Reconstruction in Patients with Tumor-Nipple Distance Less than 2.0 cm Alsharif1, E; Ryu, JM; Choi, HJ; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Lee, SK; Lee, JE
    View PubMed
  • J BREAST CANC 2019 10.4048/jbc.2019.22.e46 Omission of Chemotherapy for the Treatment of Mucinous Breast Cancer: A Nationwide Study from the Korean Breast Cancer Society Kim1, HS; Lee, JU; Yoo, TK; Chae, BJ; Son, D; Kim, YJ; Park, WC
    View PubMed
  • J BREAST CANC 2019 10.4048/jbc.2019.22.e35 Potential Benefits of Neoadjuvant Chemotherapy in Clinically Node-Positive Luminal Subtype(-) Breast Cancer Kim1, HS; Yoo, TK; Park, WC; Chae, BJ
    View PubMed
  • BMC CANCER 2019 10.1186/s12885-019-6064-8 Unmet needs and related factors of Korean breast cancer survivors: a multicenter, cross-sectional study Chae1, BJ; Lee, J; Lee, SK; Shin, HJ; Jung, SY; Lee, JW; Kim, Z; Lee, MH; Lee, J; Youn, HJ
    View PubMed